These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38863632)

  • 21. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
    Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study.
    Wang Y; Lyu Y; Che X; Li J; Feng W
    J Gynecol Oncol; 2024 May; 35(3):e36. PubMed ID: 38216135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study.
    Jiao S; Guo L; Da F; Gao Q; Ren Z; Wang J; Fu Q; Liu J
    Technol Cancer Res Treat; 2023; 22():15330338231164191. PubMed ID: 37078156
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    Yang E; Huang S; Ran X; Huang Y; Li Z
    BMC Cancer; 2021 Feb; 21(1):203. PubMed ID: 33639874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
    Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
    J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery.
    Ren X; Huang T; Tang X; Ma Q; Zheng Y; Hu Z; Wang Y; Zhou Y
    Front Oncol; 2023; 13():1223857. PubMed ID: 37655111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]   [Full Text] [Related]  

  • 31. Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study.
    Ye W; Wang Q; Lu Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13607-13618. PubMed ID: 37515614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
    Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
    BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis.
    Yi J; Liu Z; Wang L; Zhang X; Pi L; Zhou C; Mu H
    Front Oncol; 2022; 12():857375. PubMed ID: 35372011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study.
    Ke Y; Zhang Z; Li Y; Qin Y; Yang Q; Zheng C
    Eur J Surg Oncol; 2024 Apr; 50(4):108258. PubMed ID: 38484490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of colpotomic approaches on prognosis and recurrence sites of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy].
    Zhou D; Li YD; Ling KJ; Wang RW; Wang YZ; Tang S; Liang ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):49-59. PubMed ID: 36720615
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of oncological outcomes in elderly early-stage cervical cancer patients treated with radical surgery or radiotherapy: A real-world retrospective study with propensity score matching.
    Gu Y; Cheng H; Cang W; Chen L; Yang J; Xiang Y
    Front Oncol; 2023; 13():1019254. PubMed ID: 36874082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
    Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
    Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment.
    Xu C; Ma T; Sun H; Li X; Gao S
    Front Oncol; 2021; 11():659313. PubMed ID: 34150626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation.
    Zhao H; Li W; Li X; Ding Z; Zhao S
    J Thorac Dis; 2022 Dec; 14(12):4877-4893. PubMed ID: 36647503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subdivision of IIIC Stage for Endometrioid Carcinoma to Better Predict Prognosis and Treatment Guidance.
    Wen L; Zhang Y; Chen S; Wang J; Hu W; Zhong G
    Front Oncol; 2020; 10():1175. PubMed ID: 32850338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.